Personas / Equipo Humano

Carmen Muñoz Almagro

Buscador de publicaciones

Publicaciones

  • Lazarus JV, Romero D, Kopka CJ, Karim SA, Abu-Raddad LJ, Almeida G, Baptista-Leite R, Barocas JA, Barreto ML, Bar-Yam Y, Bassat Q, Batista C, Bazilian M, Chiou ST, Del Rio C, Dore GJ, Gao GF, Gostin LO, Hellard M, Jimenez JL, Kang G, Lee N, Maticic M, McKee M, Nsanzimana S, Oliu-Barton M, Pradelski B, Pyzik O, Rabin K, Raina S, Rashid SF, Rathe M, Saenz R, Singh S, Trock-Hempler M, Villapol S, Yap P, Binagwaho A, Kamarulzaman A and El-Mohandes A.

    A multinational Delphi consensus to end the COVID-19 public health threat.

    Nature . 611(7935): 332-345. Nº de citas: 109

    [doi:10.1038/s41586-022-05398-2]

  • Ciruela Navas P, Soldevila N, García-García JJ, González-Peris S, Álvaro Díaz Conradi, Redin-Alonso A, Viñado B, Izquierdo C, Munoz-Almagro C, Domínguez A, Campins M, Esteva-Afonso C, Fernández de Sevilla-Estrach M, Fernando Moraga Llop and Salleras Ll.

    Effect of COVID-19 Pandemic on Invasive Pneumococcal Disease in Children, Catalonia, Spain

    EMERGING INFECTIOUS DISEASES . 28(11): 2321-2325. Nº de citas: 7

    [doi:10.3201/eid2811.211741]

  • Sánchez-Manubens J, Henares-Bonilla D, Munoz-Almagro C, Brotons-de los Reyes P, Timoneda-Sole N and Anton-Lopez J.

    Characterization of the nasopharyngeal microbiome in patients with Kawasaki disease

    anales de pediatria . 97(5): 300-309. Nº de citas: 1

    [doi:10.1016/j.anpedi.2021.11.010]

  • Merdrignac L, Acosta L, Habington A, Garcìa Cenoz M, Pandolfi E, Fabiánová K, Jordán-García I, O'Sullivan N, Navasués A, Tozzi AE, Zavadilová J, Jané M, Cotter S, Pitillas NI, Rizzo C, Krížová P, Hanslik T, Munoz-Almagro C, Pastore L, Bacci S, Moren A and Valenciano M.

    Effectiveness of pertussis vaccination in pregnancy to prevent hospitalisation in infants aged <2 months and effectiveness of both primary vaccination and mothers vaccination in pregnancy in infants aged 2-11 months

    Vaccine . 40(44): 6374-6382. Nº de citas: 16

    [doi:10.1016/j.vaccine.2022.09.054]

  • Lo SW, Mellor K, Cohen R, Redin-Alonso A, Belman S, Kumar N, Hawkins PA, Gladstone RA, von Gottberg A, Veeraraghavan B, Ravikumar KL, Kandasamy R, Pollard SAJ, Saha SK, Bigogo G, Antonio M, Kwambana-Adams B, Mirza S, Shakoor S, Nisar I, Cornick JE, Lehmann D, Ford RL, Sigauque B, Turner P, Moïsi J, Obaro SK, Dagan R, Diawara I, Skoczynska A, Wang H, Carter PE, Klugman KP, Rodgers G, Breiman RF, McGee L, Bentley SD, Munoz-Almagro C and Varon E.

    Emergence of a multidrug-resistant and virulent Streptococcus pneumoniae lineage mediates serotype replacement after PCV13: an international whole-genome sequencing study.

    Lancet Microbe . 3(10): 735-743. Nº de citas: 36

    [doi:10.1016/S2666-5247(22)00158-6]

  • Armero-Campos G, Penela-Sánchez D, Belmonte J, Gómez-Barroso D, Larrauri A, Henares-Bonilla D, Violeta Vallejo Matavera, Jordán-García I, Munoz-Almagro C, Brotons-de los Reyes P and Launes-Montana C.

    Concentrations of nitrogen compounds are related to severe rhinovirus infection in infants. A time-series analysis from the reference area of a pediatric university hospital in Barcelona

    PEDIATRIC PULMONOLOGY . 57(9): 2180-2188.

    [doi:10.1002/ppul.26021]

  • Crovetto F, Selma-Royo M, Fàtima Crispi Brillas, Carbonetto B, Pascal-Capdevila R, Larroya M, Casas I, Tortajada M, Escudero N, Munoz-Almagro C, Gómez-Roig MD, González-Torres P, Collado MC and Gratacós E.

    Nasopharyngeal microbiota profiling of pregnant women with SARS-CoV-2 infection

    SCIENTIFIC REPORTS . 12(1): 13404-13404. Nº de citas: 8

    [doi:10.1038/s41598-022-17542-z]

  • Rocafort-Junca M, Henares-Bonilla D, Brotons-de los Reyes P, Launes-Montana C, Fernández de Sevilla-Estrach M, Fumadó V, Barrabeig I, Arias S, Redin-Alonso A, Ponomarenko J, Mele M, Millat-Martinez P, Claverol J, Balanza N, Mira A, García-García JJ, Bassat Q, Jordán-García I and Munoz-Almagro C.

    Impact of COVID-19 Lockdown on the Nasopharyngeal Microbiota of Children and Adults Self-Confined at Home

    Viruses-Basel . 14(7): . Nº de citas: 10

    [doi:10.3390/v14071521]

  • Savulescu C, Krizova P, Valentiner-Branth P, Ladhani S, Rinta-Kokko H, Levy C, Mereckiene J, Knol M, Winje BA, Ciruela Navas P, de Miguel S, Guevara M, MacDonald L, Kozakova J, Slotved HC, Fry NK, Pekka Nuorti J, Danis K, Corcoran M, van der Ende A, Vestrheim DF, Munoz-Almagro C, Sanz JC, Castilla J, Smith A, Colzani E, Pastore Celentano L and Hanquet G.

    Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SplDnet observational multicentre study

    Vaccine . 40(29): 3963-3974. Nº de citas: 44

    [doi:10.1016/j.vaccine.2022.05.011]

  • Johanna Martínez Osorio, García-García JJ, Moraga-Llop F, Díaz A, Hernández S, Solé-Ribalta A, González-Peris S, Izquierdo C, Esteva-Afonso C, Codina G, Planes AM, Uriona S, Campins M, Ciruela P, Salleras L, Domínguez Á, Munoz-Almagro C and Fernández de Sevilla-Estrach M.

    Invasive pneumococcal disease in children under 60 months before and after availability of 13-valent conjugate vaccine

    ANALES DE PEDIATRIA . 96(6): 501-510. Nº de citas: 4

    [doi:10.1016/j.anpedi.2021.05.018]